Table 4.
Repeated measures ANOVA for inflammatory markers.
| Cytokine | Significance in the Stage Model | Significance in the Week Model |
|---|---|---|
| IFN-γ | 0.20 1 | 0.47 |
| Il-1β | 0.74 | 0.86 |
| IL-1RA | 0.93 | 0.85 |
| IL-2 | 0.40 | 0.22 |
| IL-3 | NA | NA |
| IL-4 | 0.65 | 0.70 |
| IL-5 | 0.11 | 0.39 |
| IL-6 | 0.39 | 0.39 |
| IL-7 | 0.50 | 0.64 |
| IL-8 | 0.51 | 0.87 |
| IL-9 | 0.10 | 0.21 |
| IL-10 | 0.38 | 0.79 |
| IL-12p70 | 0.01 | 0.07 |
| IL-13 | 0.0005 | 0.0071 |
| IL-17A | 0.81 | 0.57 |
| TNF-α | 0.28 | 0.42 |
| Fecal calprotectin | 0.41 | 0.25 |
| Fecal lactoferrin | 0.02 | 0.13 |
1 p value for repeated measures ANOVA assessing influence of WPI intervention on serum cytokine, fecal calprotectin and fecal lactoferrin concentrations.